Osteosarcoma: conventional treatment vs. gene therapy
Tan, M, Choong, Peter F. M and Dass, Crispin R (2009) Osteosarcoma: conventional treatment vs. gene therapy. Cancer Biology and Therapy, 8 (2). pp. 106-117. ISSN 1538-4047
Abstract
Osteosarcoma (OS) remains the most common primary malignant bone cancer affecting children and adolescents. A majority of patients are subjected to surgery and chemotherapy with limited alternatives to consider. However, with increasing knowledge of the molecular pathogenesis of OS, advancements in the OS therapy research field have developed potential agents for a more targeted and localised approach to treatment. Thus, this review attempts to examine some common treatment strategies (surgery, radiotherapy and chemotherapy) employed clinically as well as recent developments in newer experimental therapy methods (gene therapy) which might benefit patients.
Dimensions Badge
Altmetric Badge
Item type | Article |
URI | https://vuir.vu.edu.au/id/eprint/7587 |
DOI | 10.4161/cbt.8.2.7385 |
Official URL | http://dx.doi.org/10.4161/cbt.8.2.7385 |
Subjects | Historical > Faculty/School/Research Centre/Department > School of Biomedical and Health Sciences Historical > FOR Classification > 1112 Oncology and Carcinogenesis Historical > SEO Classification > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) |
Keywords | ResPubID21884. osteosarcoma, bone cancer, cancer therapy, gene therapy, chemotherapy, radiotherapy, surgery, conventional medicine, experimental therapies |
Citations in Scopus | 93 - View on Scopus |
Download/View statistics | View download statistics for this item |